Troy Edward Wilson
CEO, President at Kura Oncology, Inc. (KURA); Director at Puma Biotechnology, Inc. (PBYI)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$231K
Total bought / sold$2.4M / $123K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 16SEC | PBYIPuma Biotechnology, Inc. | Sell Plan | 5,00054,750 held (−8%) | $9.10 | $46K | +13.1% |
| Aug 24SEC | KURAKura Oncology, Inc. | Buy | 100,000479,194 held (+26%) | $12.39 | $1.2M | -14.4% |
| Aug 17SEC | KURAKura Oncology, Inc. | Buy | 100,000379,194 held (+36%) | $11.12 | $1.1M | -4.7% |
| Jun 15SEC | PBYIPuma Biotechnology, Inc. | Sell Plan | 10,80059,750 held (−15%) | $7.20 | $78K | +42.9% |
- Sell
Director Troy Edward Wilson sold $46K of PBYI at $9.10 — pre-scheduled 10b5-1 plan sale.
- Buy
CEO, President Troy Edward Wilson bought $1.2M of KURA at $12.39 — largest purchase by this insider in our records; raises the stake by 26%.
- Buy
CEO, President Troy Edward Wilson bought $1.1M of KURA at $11.12 — first open-market purchase in our records; raises the stake by 36%.
- Sell
Director Troy Edward Wilson sold $78K of PBYI at $7.20 — pre-scheduled 10b5-1 plan sale.